New papulovesicular rash in the course of COVID-19 signaling viral reactivation
Rev. Assoc. Med. Bras. (1992)
;
67(2): 182-184, Feb. 2021. graf
Article
in English
| LILACS
| ID: biblio-1287816
ABSTRACT
SUMMARY Cutaneous manifestations are considered an infrequent presentation of coronavirus disease 2019 (COVID-19) and are mostly described in outpatient settings. Its onset during the course of the severe COVID-19 disease has been poorly described in severe cases. Studies focused on dermatological manifestations mostly described maculopapular or pernio-like lesions and less frequently vesicular or varicella-like eruption. We described the occurrence of a vesiculopapular eruption in three laboratory-confirmed COVID-19 patients associated with severe lung injury in whom the skin findings preceded viral reactivation and recrudescence of hypoxemia. The potential mechanisms for COVID-19-related cutaneous manifestations include immune hypersensitivity, cytokine-release syndrome, deposition of microthrombi, and vasculitis.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Exanthema
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Rev. Assoc. Med. Bras. (1992)
Year:
2021
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital de Clínicas de Porto Alegre/BR
Similar
MEDLINE
...
LILACS
LIS